dexpramipexole in a sentence
- In September 2009, dexpramipexole received Fast Track designation for ALS from the U . S . Food and Drug Administration ( FDA ).
- In January 2013, Biogen Idec announced that it was discontinuing its development of dexpramipexole in ALS due to lack of efficacy in a Phase III study.
- Dexpramipexole is a low molecular weight, water-soluble, orally bioavailable, renally excreted compound with linear pharmacokinetics, and has been shown to be well tolerated in human subject testing.
- "' Dexpramipexole "'( "'KNS-760704 "') is a drug that was investigated by Knopp Biosciences and Biogen Idec for the treatment of amyotrophic lateral sclerosis ( ALS ), also known as Lou Gehrig s disease.
- It's difficult to find dexpramipexole in a sentence.